Nifoxipam Stats & Data
O=N(=O)c1ccc2NC(=O)C(O)N=C(c3ccccc3F)c2c1UHFIFTRHLBAWGY-UHFFFAOYSA-NInteraction Warnings
This combination can result in an increased risk of vomiting during unconsciousness and death from the resulting suffocation. If this occurs, users should attempt to fall asleep in the recovery position or have a friend move them into it.
It is dangerous to combine benzodiazepines with stimulants due to the risk of excessive intoxication. Stimulants decrease the sedative effect of benzodiazepines, which is the main factor most people consider when determining their level of intoxication. Once the stimulant wears off, the effects of benzodiazepines will be significantly increased, leading to intensified disinhibition as well as other effects.
Receptor Profile
Receptor Actions
History & Culture
Nifoxipam is a nitrobenzodiazepine that was originally identified as a minor metabolite of flunitrazepam (marketed as Rohypnol). While it exists primarily as an analytical reference material in pharmacological research, the compound has since emerged on the online designer drug market. It is currently sold by research chemical vendors as a recreational psychoactive substance. Despite having potential applications for the short-term treatment of anxiety, insomnia, acute seizures, and sedation of hospitalized patients, nifoxipam has never been approved for medicinal use and remains unscheduled in most jurisdictions. The compound represents part of the broader trend of benzodiazepine metabolites and analogues appearing in the grey-market research chemical trade.
Subjective Effect Notes
physical: The physical effects of nifoxipam can be broken down into several components which progressively intensify proportional to dosage.
cognitive: The general head space of nifoxipam is described by many as one of intense sedation and decreased inhibition. It contains a large number of typical depressant cognitive effects.
Effect Profile
Curated + 1 ReportsStrong anxiolysis and cognitive impairment with moderate sedation and euphoria
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Cross-Tolerances
Experience Report Analysis
ErowidDemographics
Gender Distribution
Age Distribution
Reports Over Time
Legal Status
| Country | Status | Notes |
|---|---|---|
| Canada | Schedule IV CDSA | Controlled as a benzodiazepine under Schedule IV of the Controlled Drugs and Substances Act. All benzodiazepines fall under this scheduling regardless of specific listing. |
| Germany | NpSG (Controlled) | Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since July 18, 2019. Production, import with intent to distribute, administration to others, and trading are criminal offenses. Possession is prohibited but carries no criminal penalty. |
| Russia | Schedule III | Classified as a Schedule III controlled substance since 2017. Subject to restrictions on possession, distribution, and manufacturing. |
| Switzerland | Verzeichnis E (Controlled) | Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics scheduling. Possession and distribution require authorization. |
| Turkey | Illegal | Classified as a controlled drug under national legislation. Possession, production, supply, and importation are prohibited. |
| United Kingdom | Psychoactive Substances Act 2016 | Controlled under the Psychoactive Substances Act, effective May 26, 2016. Production, supply, and importation are criminal offenses. Personal possession is not criminalized under this act, though intent to supply remains prosecutable. |
References
Cited References
- Analytical and Bioanalytical Chemistry - Identification of main human urinary metabolites
- BenchChem - Nifoxipam pharmacokinetic summary
- Bluelight: Nifoxipam user experience thread
- Drugs-Forum: Nifoxipam and Flubromazolam discussion
- Forensic Toxicology - Metabolites replace the parent drug
- Headwaters Recovery - Nifoxipam harm reduction overview
- Novel Designer Benzodiazepines - Comprehensive review
- PMC: Fonazepam and nifoxipam comprehensive review
- TripSit: Nifoxipam factsheet
- TripSit: Drug combination chart
- Urine LC-HRMS panel for designer benzodiazepines